Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Common Equity (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Common Equity for 16 consecutive years, with $37.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity rose 27.06% year-over-year to $37.0 million, compared with a TTM value of $37.0 million through Sep 2025, up 27.06%, and an annual FY2024 reading of $32.6 million, up 53.05% over the prior year.
  • Common Equity was $37.0 million for Q3 2025 at Rockwell Medical, up from $30.4 million in the prior quarter.
  • Across five years, Common Equity topped out at $37.0 million in Q3 2025 and bottomed at -$4.8 million in Q1 2022.
  • Average Common Equity over 5 years is $19.6 million, with a median of $20.6 million recorded in 2024.
  • Peak annual rise in Common Equity hit 456.45% in 2022, while the deepest fall reached 118.36% in 2022.
  • Year by year, Common Equity stood at $2.5 million in 2021, then skyrocketed by 456.45% to $14.1 million in 2022, then skyrocketed by 50.94% to $21.3 million in 2023, then soared by 53.05% to $32.6 million in 2024, then increased by 13.61% to $37.0 million in 2025.
  • Business Quant data shows Common Equity for RMTI at $37.0 million in Q3 2025, $30.4 million in Q2 2025, and $31.5 million in Q1 2025.